KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Debt to Equity (2019 - 2026)

GoodRx Holdings' Debt to Equity history spans 7 years, with the latest figure at $0.79 for Q4 2025.

  • On a quarterly basis, Debt to Equity rose 16.76% to $0.79 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.79, a 16.76% increase, with the full-year FY2025 number at $0.79, up 16.76% from a year prior.
  • Debt to Equity hit $0.79 in Q4 2025 for GoodRx Holdings, down from $0.81 in the prior quarter.
  • Over the last five years, Debt to Equity for GDRX hit a ceiling of $1.04 in Q1 2024 and a floor of $0.68 in Q4 2024.
  • Historically, Debt to Equity has averaged $0.81 across 5 years, with a median of $0.8 in 2021.
  • Biggest five-year swings in Debt to Equity: surged 32.92% in 2024 and later fell 27.59% in 2025.
  • Tracing GDRX's Debt to Equity over 5 years: stood at $0.8 in 2021, then grew by 1.44% to $0.81 in 2022, then grew by 6.56% to $0.86 in 2023, then dropped by 21.24% to $0.68 in 2024, then grew by 16.76% to $0.79 in 2025.
  • Business Quant data shows Debt to Equity for GDRX at $0.79 in Q4 2025, $0.81 in Q3 2025, and $0.76 in Q2 2025.